Drastic neuronal loss in vivo by β-amyloid racemized at Ser26 residue: conversion of non-toxic [D-Ser26]β-amyloid 1–40 to toxic and proteinase-resistant fragments
- 10 July 2001
- journal article
- Published by Elsevier in Neuroscience
- Vol. 104 (4) , 1003-1011
- https://doi.org/10.1016/s0306-4522(01)00155-5
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Familial Alzheimer's Disease–Linked Presenilin 1 Variants Elevate Aβ1–42/1–40 Ratio In Vitro and In VivoNeuron, 1996
- Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic MiceScience, 1996
- Suppression of Mitochondrial Succinate Dehydrogenase, a Primary Target of β‐Amyloid, and Its Derivative Racemized at Ser ResidueJournal of Neurochemistry, 1995
- Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor proteinNature, 1995
- Hydrogen peroxide mediates amyloid β protein toxicityCell, 1994
- Thioflavine T interaction with synthetic Alzheimer's disease β‐amyloid peptides: Detection of amyloid aggregation in solutionProtein Science, 1993
- Neuritic Plaque Amyloid in Alzheimer's Disease Is Highly RacemizedJournal of Neurochemistry, 1988
- Occurrence of neuropathological changes and dementia of Alzheimer's disease in Down's syndromeAnnals of Neurology, 1985
- [D-Ala 2 ]-Met-Enkephalinamide: A Potent, Long-Lasting Synthetic Pentapeptide AnalgesicScience, 1976
- Computed circular dichroism spectra for the evaluation of protein conformationBiochemistry, 1969